Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans

This publication has 35 references indexed in Scilit:

• Seasonal inactivated influenza virus vaccines
  Vaccine, 2008
• A dose–response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
  Vaccine, 2007
• Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant
  Vaccine, 2007
• Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers
  Journal of Virology, 2006
• Interferons as pathogenic effectors in autoimmunity
  Immunological Reviews, 2005
• A Non-Living Nasal Influenza Vaccine Can Induce Major Humoral and Cellular Immune Responses in Humans without the Need for Adjuvants
  Human Vaccines, 2005
• Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine
  Vaccine, 2004
• Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration
  Vaccine, 2000
• Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
  Vaccine, 1996
• Efficacy and Tolerance of Intranasally Applied Recombinant Leukocyte A Interferon in Normal Volunteers
  The Journal of Infectious Diseases, 1983